Article
The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.
Blood - 9 Nov 2017
Colucci Silvia, Pagani Alessia, Pettinato Mariateresa, Artuso Irene, Nai Antonella, Camaschella Clara, Silvestri Laura
Abstract excerpt
The expression of the key regulator of iron homeostasis hepcidin is activated by the BMP-SMAD pathway in response to iron and inflammation and among drugs, by rapamycin, which inhibits mTOR in complex with the immunophilin FKBP12. FKBP12 interacts with BMP type I receptors to avoid uncontrolled signaling. By pharmacologic and genetic studies, we identify FKBP12 as a novel hepcidin regulator. Sequestration of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
